How The Molecule Platform Works
Molecule is an exchange nexus for biopharma intellectual property.
Researchers &
Institutions
CHALLENGES
Early-stage drug development projects often get stuck in "The Valley of Death"
There is a need for more funding and support for commercially viable therapeutics from universities.
Scientists and universities struggle to get global visibility for their work.
There is a need for more funding and support for commercially viable therapeutics from universities.
Scientists and universities struggle to get global visibility for their work.
The Molecule
Platform
SOLUTION
Discover global licensing, co-development, and investment opportunities for novel therapeutic technologies.
Fractionalise your assets and access financing and support using novel Web3.0 structures.
Turn IP into a highly liquid asset class.
Fractionalise your assets and access financing and support using novel Web3.0 structures.
Turn IP into a highly liquid asset class.
Biopharma
Investors
CHALLENGES
Quality deal flow can be difficult to source, evaluate, and DD.
IP is a highly illiquid asset class with many barriers to investment.
Biotech investment is not accessible to many stakeholders, including patients that stand to benefit the most.
IP is a highly illiquid asset class with many barriers to investment.
Biotech investment is not accessible to many stakeholders, including patients that stand to benefit the most.
How Assets Come to Market on Molecule
A modular drug development pipeline.
The Molecule Tech Stack
Decentralized Finance and Fractional IP
Our long-term goal is to decentralize ownership, financing and governance processes within drug development. To achieve this, we are pioneering approaches to fractional and decentralized IP and data ownership.
Making IP natively digital by attaching ownership and distributing it as Non-Fungible Tokens (NFTs).
Creating liquid IP markets via autonomous algorithmic market makers and decentralised finance.
Providing private and secure data storage with the ability to share with select users.
Learn more on our Medium Blog.
Inspired? Connect with our team and learn more.
